Discover
NLSP
NLS Pharmaceutics AG
0.76
2 x 0.57
2 x 0.99
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | -96.39% | |
| 1y | -98.03% |
0.76
day range
0.83
1.73
52 week range
24.32
| Open | 0.77 | Prev Close | 0.76 | Low | 0.76 | High | 0.83 | Mkt Cap | 4.69M |
| Vol | 30.34M | Avg Vol | 380.73K | EPS | -6.74 | P/E | N/A | Forward P/E | -3.60 |
| Beta | -0.52 | Short Ratio | 0.15 | Inst. Own | 19.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.46 | 200-d Avg | 5.96 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 4.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.07M | ||
| Cash and Equivalents (USD) | 3.07M | ||
| Current Assets | 4.04M | ||
| Property, Plant & Equipment Net | 5.30K | ||
| Total Assets | 4.34M | ||
| Total Liabilities | 1.46M | ||
| Accumulated Retained Earnings (Deficit) | -74.81M | ||
| Accumulated Other Comprehensive Income | 108.85K | ||
| Shareholders Equity | 2.88M | ||
| Shareholders Equity (USD) | 2.88M | ||
| Assets Non-Current | 301.74K | ||
| Trade and Non-Trade Payables | 1.02M | ||